You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloid Hematological Malignancies

Showing 1 - 25 of 6,468
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • NTQ2494 tablet
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 17, 2023

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Beijing (Ex-vivo expanded ?d T cell infusion)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Ex-vivo expanded γδ T cell infusion
  • Beijing, China
    Chinese PLA General Hospital
Mar 24, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • TQB2928 Injection + Azacitidine for injection
  • Beijing, Beijing, China
  • +8 more
Aug 22, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Helsinki, Finland
  • +3 more
Jun 29, 2022

High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

Terminated
  • High-risk Myelodysplastic Syndromes
  • +3 more
  • GTB-3550 TriKE® Phase I
  • GTB-3550 TriKE® Phase II
  • Minneapolis, Minnesota
  • +1 more
Mar 21, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
Has Results
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham

Completed
Has Results
  • Acute Lymphoblastic Leukemia (ALL)
  • +4 more
  • Maywood, Illinois
  • +1 more
Aug 1, 2021

Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

Recruiting
  • Non-Hodgkin Lymphoma (NHL)
  • +2 more
  • Gent, Belgium
  • +9 more
Mar 18, 2022

Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor

Recruiting
  • Leukemia
  • +3 more
  • Phenotyping of total and innate CD8+T cells by flow cytometry
  • Nîmes, Gard, France
    CHU de Nîmes
Jul 19, 2021

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Hematological Malignancies - SANGUINE

    Recruiting
    • Hematologic Malignancy
    • Blood sampling for HemaChip screening/diagnostic testing
    • Bone marrow sampling
    • Olomouc, Czechia
    • +3 more
    Feb 9, 2023

    Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)

    Terminated
    Has Results
    • Mantle Cell Lymphoma
    • +4 more
    • cellular immunotherapy
    • Providence, Rhode Island
    • +1 more
    Feb 23, 2022

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023